No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
PYXS Pyxis Oncology
- 4.360
- +0.060+1.40%
Trading Apr 26 11:05 ET
253.47MMarket Cap-2356P/E (TTM)
4.410High4.250Low41.27KVolume4.270Open4.300Pre Close179.97KTurnover0.12%Turnover RatioLossP/E (Static)58.13MShares6.85052wk High2.02P/B154.37MFloat Cap1.35052wk Low--Dividend TTM35.41MShs Float19.000Historical High--Div YieldTTM3.72%Amplitude1.100Historical Low4.360Avg Price1Lot Size
Intraday
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
HROW, HCAT and EGRX Are Among After Hour Movers
Express News | HC Wainwright & Co. Reiterates Buy on Pyxis Oncology, Maintains $7 Price Target
Signet Jewelers, Dave & Buster's Entertainment, Blue Owl Capital And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were higher, with the Dow Jones gaining over 50 points on Wednesday. Shares of Signet Jewelers Limited (NYSE:SIG) rose sharply during Wednesday's session after the company raised its FY25
Analysts Offer Insights on Healthcare Companies: Aura Biosciences Inc (AURA), Spectral AI (MDAI) and Pyxis Oncology (PYXS)
Pyxis Oncology Files to Sell 10.46M Common Shares for Holders
Pyxis Oncology Gets $8M Payment for Sale Pf Royalty Rights
Comments
The insider transactions at Pyxis Oncology do not provide much encouragement. However, the fact that insiders own a significant portion of the company suggests a reasonable degree of alignment with other shareholders.
Insiders Who Sold Pyxis Oncology Made The Right Call As Market Cap Slides By US$50m 1
Oncology Research Company Secures $50 Million Private Placement
Pyxis Oncology Announces $50 Million Private Placement: Urgent Developments in Cancer Research.
In an urgent and significant development in the field of oncology research, Pyxis Oncology (NASDAQ: $PYXS) recently announced a $50 million private placement. This news comes as a major step forward for the company and its efforts to advance the development of new cancer treatments. $Pyxis Oncology(PYXS.US$
https://stockregion.app/p/oncology-research-company-secures
In an urgent and significant development in the field of oncology research, Pyxis Oncology (NASDAQ: $PYXS) recently announced a $50 million private placement. This news comes as a major step forward for the company and its efforts to advance the development of new cancer treatments. $Pyxis Oncology(PYXS.US$
https://stockregion.app/p/oncology-research-company-secures
Buy ^^
$Pyxis Oncology(PYXS.US$
Plus the dude who analyzed the target price has a 100% success rate in his analyses! He's not a dummy ^^
Plus the dude who analyzed the target price has a 100% success rate in his analyses! He's not a dummy ^^
strong potentiel, strong buy
$Pyxis Oncology(PYXS.US$
top gainers yesterday, I cheked it and I think it has great potential.
"strong buy"
top gainers yesterday, I cheked it and I think it has great potential.
"strong buy"
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg